Search hospitals > Georgia > Marietta
Wellstar/Kennestone Hospital
Claim this profileMarietta, Georgia 30060
Global Leader in Cancer
Conducts research for Coronary Artery Disease
Conducts research for Breast Cancer
Conducts research for Stroke
Conducts research for Recurrence
83 reported clinical trials
11 medical researchers
Summary
Wellstar/Kennestone Hospital is a medical facility located in Marietta, Georgia. This center is recognized for care of Cancer, Coronary Artery Disease, Breast Cancer, Stroke, Recurrence and other specialties. Wellstar/Kennestone Hospital is involved with conducting 83 clinical trials across 169 conditions. There are 11 research doctors associated with this hospital, such as Hans Lee, MD, Amar Patel, MD, Rishi Gupta, MD, and Salvatore Mannino, DO.Area of expertise
1Cancer
Global LeaderStage III
Stage IV
Stage II
2Coronary Artery Disease
Top PIs
Hans Lee, MDM D Anderson Cancer Center1 year of reported clinical research
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
7 reported clinical trials
12 drugs studied
Amar Patel, MDWellStar Kennestone Hospital6 years of reported clinical research
Studies Cardiovascular Disease
Studies Stroke
7 reported clinical trials
11 drugs studied
Rishi Gupta, MDWellStar Kennestone Regional Medical Center2 years of reported clinical research
Studies Stroke
Studies Ischemic Stroke
5 reported clinical trials
6 drugs studied
Salvatore Mannino, DOWellstar Kennestone Hospital2 years of reported clinical research
Studies Coronary Artery Disease
Studies Heart Attack
4 reported clinical trials
4 drugs studied
Clinical Trials running at Wellstar/Kennestone Hospital
Stroke
Mitral Valve Regurgitation
Coronary Artery Disease
Heart Attack
Myocardial Infarction or Heart Attack
Left Ventricular Dysfunction
Myocardial Infarction
Bleeding
Aneurysm
Ischemic Stroke
Mechanical Thrombectomy
for Stroke
This trial is testing a device called the Penumbra System with Thunderbolt, which removes blood clots from the brain. It targets patients who have had a stroke due to a large vessel blockage and are eligible for clot removal procedures. The device works like a vacuum to clear the blockage and restore blood flow. The Penumbra System has been previously reported to be effective and safe in treating acute stroke caused by large intracranial vessel occlusion.
Recruiting1 award N/A7 criteria
rFVIIa
for Hemorrhagic Stroke
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit, will improve outcomes at 180 days as measured by the Modified Rankin Score (mRS) and decrease ongoing bleeding as compared to standard therapy.
Recruiting1 award Phase 34 criteria
Apixaban vs Aspirin
for Stroke Prevention in Atrial Fibrillation After Brain Bleed
Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in better functional outcomes as measured by the modified Rankin Scale.
Recruiting1 award Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Wellstar/Kennestone Hospital?
Wellstar/Kennestone Hospital is a medical facility located in Marietta, Georgia. This center is recognized for care of Cancer, Coronary Artery Disease, Breast Cancer, Stroke, Recurrence and other specialties. Wellstar/Kennestone Hospital is involved with conducting 83 clinical trials across 169 conditions. There are 11 research doctors associated with this hospital, such as Hans Lee, MD, Amar Patel, MD, Rishi Gupta, MD, and Salvatore Mannino, DO.